Theravance Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 9 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Theravance Biopharma Inc
TickerTBPH
CIK #0001583107
CUSIPG8807B106
SectorLife Sciences - Pharmaceutical Preparations
AddressUgland House, South Church Street, George Town, Grand Cayman, KY1-1104
Source [EDGAR]
CIK Filing 2011 - 2026
[0001583107] 10-K
[0001583107] 10-Q
[0001583107] 3
[0001583107] 4
[0001583107] 8-K
[0001583107] SC 13D
[0001583107] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Newtyn Management LLC Theravance Biopharma Inc [2024-08-16] 8.4
Irenic Capital Management LP Theravance Biopharma Inc [2024-02-14] 5.5
Weiss Asset Management LP Theravance Biopharma Inc [2023-04-12] 11.79
Barclays PLC Theravance Biopharma Inc [2023-01-30] 5.0
Weiss Asset Management LP Theravance Biopharma Inc [2022-06-16] 8.09
ODRE 2005 SLU Theravance Biopharma Inc [2022-04-21] 5.5
Madison Avenue Partners LP Theravance Biopharma Inc [2021-09-27] 6.2
Point72 Asset Management LP Theravance Biopharma Inc [2021-09-07] 6.9
OrbiMed Advisors LLC Theravance Biopharma Inc [2021-02-12] 8.67
Acacia Research Corp Theravance Biopharma Inc [2020-06-11] 0.0
Wellington Management Group LLP Theravance Biopharma Inc [2020-01-28] 5.6
Link Fund Solutions Ltd Theravance Biopharma Inc [2019-10-29] 0.27
Vanguard Group Inc Theravance Biopharma Inc [2017-02-10] 5.68
FMR LLC Theravance Biopharma Inc [2016-11-10] 0.0
GlaxoSmithKline PLC Theravance Biopharma Inc [2016-03-24] 24.3
CF Woodford Equity Income Fund Theravance Biopharma Inc [2015-11-10] 10.5
Woodford Investment Management LLP Theravance Biopharma Inc [2015-11-10] 11.2
GlaxoSmithKline PLC Theravance Biopharma Inc [2015-09-02] 24.5
Baupost Group LLC/MA Theravance Biopharma Inc [2015-02-13] 18.81
BlackRock Inc Theravance Biopharma Inc [2015-02-02] 6.3
Form 3/4/5 Filer 2011 - 2026
Theravance Biopharma Inc
Samaha Eli
Miller Aine
Farnum Rhonda
Smaldone Alsup Laurie
Pakianathan Deepika
O'Connor Donal
Gray Susannah
Mitchell Dean J
Sawaf Aziz
Grimaud Brett A
Winningham Rick E
Broshy Eran
Grant Jeremy T
Graham Richard A
Malkiel Burton G
Kelly James Connor
Hindman Andrew A
WAM GP LLC
Weiss Andrew M
Weiss Asset Management LP
GlaxoSmithKline PLC
Young William D
Pitzer Kenneth R
Brady Ann
Pasqualone Frank
Worboys Philip D
Sabesan Vijay
Shafer Bradford J
Whitesides George M
Molineaux Susan
Gunderson Robert V JR
Haumann Brett K
Hegde Sharathchandra S
Ringrose Peter S
Suliman Shehnaaz
Gala Renee D
Fore Henrietta
Lee Junning
Mammen Mathai
Blum Leonard M
Jonker Jeffrey David
Atieh Michael G
Theravance Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Farnum Rhonda
Ordinary Shares
2026-03-16 Sell 15,534 $14.00 217,476
Farnum Rhonda
Ordinary Shares
2026-03-16 Sell 7,766 $13.92 108,103
Farnum Rhonda
Ordinary Shares
2026-03-16 Sell 7,767 $13.92 108,117
Miller Aine
Ordinary Shares
2026-02-20 Tax withheld 16,851 $19.66 331,291
Winningham Rick E
Ordinary Shares
2026-02-20 Tax withheld 74,975 $19.66 1,474,008
Grimaud Brett A
Ordinary Shares
2026-02-20 Tax withheld 20,833 $19.66 409,577
Farnum Rhonda
Ordinary Shares
2026-02-20 Tax withheld 13,929 $19.66 273,844
Sawaf Aziz
Ordinary Shares
2026-02-20 Tax withheld 20,672 $19.66 406,412
Farnum Rhonda
Ordinary Shares
2025-12-03 Sell 7,766 $18.75 145,612
Farnum Rhonda
Ordinary Shares
2025-12-03 Sell 15,534 $18.75 291,262
Farnum Rhonda
Ordinary Shares
2025-12-03 Sell 7,767 $18.75 145,631
Broshy Eran
Share Option (Right to Buy) · derivative
2025-11-26 Option exercise 14,000 $10.15 142,100
Broshy Eran
Ordinary Shares
2025-11-26 Sell 15,501 $20.00 310,020
Broshy Eran
Ordinary Shares
2025-11-26 Sell 14,000 $20.00 280,000
Miller Aine
Ordinary Shares
2025-11-20 Tax withheld 6,989 $17.90 125,103
Winningham Rick E
Ordinary Shares
2025-11-20 Tax withheld 56,817 $17.90 1,017,024
Grimaud Brett A
Ordinary Shares
2025-11-20 Tax withheld 19,024 $17.90 340,530
Farnum Rhonda
Ordinary Shares
2025-11-20 Tax withheld 9,060 $17.90 162,174
Sawaf Aziz
Ordinary Shares
2025-11-20 Tax withheld 18,627 $17.90 333,423
Winningham Rick E
Ordinary Shares
2025-11-19 Gift 9,900 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 174 48,711,472
2025-12-31 171 48,310,613
2025-09-30 162 47,505,780
2025-06-30 136 46,574,114
2025-03-31 133 44,891,381
2024-12-31 129 44,888,620
2024-09-30 120 45,939,035
2024-06-30 133 47,225,088
2024-03-31 124 48,722,642
2023-12-31 121 49,158,720
2023-09-30 117 50,764,567
2023-06-30 122 52,537,582
Form 13F Holdings
Firm Period DFND Voting Shares
CWA Asset Management Group LLC [2026-06-30] SOLE 205 134,994
Wedge Capital Management L L P/NC [2026-06-30] SOLE 42,130 128,845
Sierra Summit Advisors LLC [2026-06-30] SOLE 0 59,096
Juncture Wealth Strategies LLC [2026-06-30] SOLE 17,234 17,234
Ballentine Partners LLC [2026-06-30] OTR 0 14,321
Equitec Proprietary Markets LLC [2026-06-30] SOLE 5,000 10,000
Thompson Investment Management Inc [2026-06-30] SOLE 3,046 3,046
Gamma Investing LLC [2026-06-30] DFND 535 535
Versant Capital Management Inc [2026-06-30] SOLE 493 493
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 327 327
Fortitude Family Office LLC [2026-06-30] SOLE 158 158
Farther Finance Advisors LLC [2026-06-30] SOLE 0 50
Nova Wealth Management Inc [2026-06-30] SOLE 42 42
Ballentine Partners LLC [2026-06-30] SOLE 0 41
IFP Advisors LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com